Topical brimonidine reduces IPL-induced erythema without affecting efficacy: A randomized controlled trial in patients with facial telangiectasias. [electronic resource]
Producer: 20190905Description: 1002-1009 p. digitalISSN:- 1096-9101
- Administration, Topical
- Adrenergic alpha-2 Receptor Agonists -- administration & dosage
- Brimonidine Tartrate -- administration & dosage
- Edema -- prevention & control
- Erythema -- prevention & control
- Face
- Female
- Humans
- Laser Therapy -- methods
- Male
- Middle Aged
- Postoperative Complications -- prevention & control
- Single-Blind Method
- Telangiectasis -- surgery
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.